izpis_h1_title_alt

Zanesljivost in veljavnost lestvice za merjenje stopnje kronične utrujenosti pri osebah po kapi : magistrsko delo
ID Lešnik, Tjaša (Author), ID Tomažin, Katja (Mentor) More about this mentor... This link opens in a new window

.pdfPDF - Presentation file, Download (1,79 MB)
MD5: E4C5D49E028142CE059F7F05BC41E9A7

Abstract
V slovenski jezik prevedena Lestvica stopnje utrujenosti (LSU) je zanesljivo in občutljivo orodje za ugotavljanje kronične utrujenosti pri osebah v kronični fazi po možganski kapi. Za določanje kronične utrujenosti je bila uporabljena mejna vrednost > ali ≥ 4. Prevalenca utrujenosti pri osebah v kronični fazi po možganski kapi je bila 73 %. Osebe z ortopedskimi obolenji imajo nižjo prevalenco utrujenosti kakor osebe v kronični fazi po možganski kapi in znaša 57%. Pri prvem merjenju LSU je več kot 50 % oseb z ortopedskimi obolenji na šestih trditvah odgovorilo z oceno 4 ali višje, pri drugi meritvi pa pri 8 trditvah. Pri tretji in osmi trditvi so osebe z ortopedskimi obolenji redko odgovorile (46 %) nad mejno vrednostjo. Z oceno 4 ali več, je več kot 70 % oseb v kronični fazi po možganski kapi odgovorilo na vseh 9 vprašanj testa LSU. Pri prvi trditvi sta imeli obe skupini najvišji odstotek odgovorov nad mejno vrednostjo, tako pri prvi meritvi kakor tudi pri drugi. Pri prvem merjenju sta z najnižjim odstotkom nad vrednostjo > ali ≥ 4 odgovorili na zadnjo, deveto trditev (40,1 % pri oseb z ortopedskimi obolenji in 73,2 % pri osebah v kronični fazi po možganski kapi. Pri drugem merjenju pa je skupina z ortopedskimi obolenji imela najnižji % odgovorov nad mejno vrednostjo pri 3. trditvi (46,6 %). Skupina v kronični fazi po možganski kapi je na drugem merjenju LSU z najnižjim % nad mejno vrednostjo odgovorila na trditvi 3 in 6 (73,2 %). LSU je imel dobro notranjo zanesljivost pri osebah z ortopedskimi obolenji, pri osebah v kronični fazi po možganski kapi pa odlično, saj je Cronbach α znašal 0,897 in 0,997. ICC je bil za osebe po kapi 0,955 (posamezne meritve) in 0,977 (povprečje meritev) ter za osebe z ortopedskimi obolenji 0,813 (posamezne meritve) in 0,897 (povprečje meritev). Vidna analogna lestvica ni občutljiva za razlikovanje utrujenosti med osebami z ortopedskimi obolenji in osebami v kronični fazi po možganski kapi. LSU je malenkost bolj občutljiva, vendar tudi slednja ne razlikuje utrujenosti med osebami z ortopedskimi obolenji in osebami v kronični fazi po kapi. Trditve 3, 8 in 9 najbolj diskriminirajo med utrujenostjo pri osebah z ortopedskimi obolenji in osebami v kronični fazi po možganski kapi.

Language:Slovenian
Keywords:Lestvica stopnje utrujenosti, možganska kap, Vidna analogna lestvica, kronična utrujenost
Work type:Master's thesis/paper
Typology:2.09 - Master's Thesis
Organization:FŠ - Faculty of Sport
Year:2021
PID:20.500.12556/RUL-131778 This link opens in a new window
COBISS.SI-ID:105594627 This link opens in a new window
Publication date in RUL:03.10.2021
Views:1287
Downloads:106
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Title:Validity and reliability of the Fatigue severity scale for measuring chronic fatigue in stroke
Abstract:
The Fatigue severity scale translated into Slovenian language (LSU) is a reliable and sensitive tool for determining chronic fatigue in stroke. A cut-off value > ali ≥ 4 was used to determine chronic fatigue. The prevalence of fatigue in subjects in the chronic phase after stroke was 73 %. People with orthopedic diseases have a lower prevalence (57 %) of fatigue than the people in the chronic phase after a stroke. In the first measurement of LSU, more than 50 % of all people with orthopedic diseases responded to six claims with a score of 4 or higher, and in second measurement to 8 claims. At the 3rd and 8th claim people with orthopedic diseases rarely responded above the limit (46 %). With a score of 4 or higher, more than 70 % of all people in the cronic phase after a stroke answered all 9 LSU test claims. At the 1st statement, both groups had the highest percentage of responses above the threshold, both in the first measurement and in the second. In the first measurement they answered the last, ninth claim with the lowest percentage above > ali ≥ 4 (40,1 % in pearsons with orthopedic diseases and 73,2% in pearsons in the chronic phase after stroke). In the second measurement, the group with orthopedic diseases had the lowest % of responses above the threshold in 3rd claim. The group in the chronic phase after stroke responded to claims 3 and 6 in the second measurement of LSU with the lowest % above the threshold (73,2 %). LSU had a good internal reliability in individuals with orthopedic disease and excellent in individuals in the chronic phase after stroke, as Cronbach α was 0,897 and 0,997, respectively. The ICC was 0,955 (individual measurements) and 0,977 (average of measurements) for pearsons after stroke and 0,813 (individual measurements) and 0,897 (average of measurements) for persons with orthopedic diseases. The Visual analog scale (VAL) is not sensible to distinguish fatigue between pearsons with orthopedic diseases and pearsons in the chronic phase after stroke. LSU is slightly more sensible, but is still not able to distinguish fatigue between groups. Claim 3, 8 and 9 most distinguish between fatigue in people with orthopedic disease and people in the chronic phase after a stroke.

Keywords:Fatigue severity scale, stroke, Visual analog scale, chronic fatigue

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back